immatics biotechnologies GmbH Capital Reinvestment Ratio
immatics biotechnologies GmbH capital reinvestment ratio. immatics biotechnologies GmbH (4A3) has a Capital Reinvestment Ratio of 0.12x as of December 2023, meaning it reinvests 0% of its operating cash flow (€79.08 Million) in capital expenditures (€9.29 Million). Check total reinvestment intensity of immatics biotechnologies GmbH to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of immatics biotechnologies GmbH (2018–2023)
Capital reinvestment ratio of immatics biotechnologies GmbH from 2018 to 2023. This chart tracks immatics biotechnologies GmbH's Capital Reinvestment Ratio across 6 annual periods. Also explore net asset momentum of immatics biotechnologies GmbH to track the company's year-over-year net asset growth rate.
immatics biotechnologies GmbH Capital Reinvestment Ratio by Year (2018–2023)
immatics biotechnologies GmbH capital reinvestment ratio by year from 2018 to 2023. For the full cash flow conversion analysis, see 4A3 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.70x | €18.23 Million | €30.96 Million | ▲ +2863.7% |
| 2022 | 0.06x | €100.13 Million | €5.74 Million | ▲ +12.4% |
| 2021 | 0.05x | €100.13 Million | €5.11 Million | ▼ -31.2% |
| 2020 | 0.07x | €100.13 Million | €7.42 Million | ▲ +145.4% |
| 2019 | 0.03x | €70.97 Million | €2.14 Million | ▲ +45.6% |
| 2018 | 0.02x | €20.68 Million | €429.00K | — |